Report Highlights
The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.
Report Includes
- An overview of the global markets for allergy diagnostics and treatments.
- Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
- Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
- Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
- Profiles of major players in the allergy diagnostics and treatments industry.
Report Scope
This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).
The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:
- A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
- An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
- Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
- A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.
Analyst Credentials
Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to producing business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:
- Various medical device markets.
- High-growth and niche markets in healthcare and life sciences.
- Home healthcare market.
- Medical tourism.
Report Highlights
Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.
Report Includes
- An overview of the global markets for allergy diagnostics and treatments.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
- Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
- Profiles of major players in the allergy diagnostics and treatments industry.
Report Highlights
- The total, current U.S. prescription allergy treatment and management market in 2001 generated revenues of $6.45 billion. In 2006, this market is forecast to reach $9.6 billion, rising at an average annual growth rate (AAGR) of 8.3%.
- The antihistamines and combinations segment reached $2.90 billion in 2001, some 45% of the market. Growing at an AAGR of 6.7%, this segment will reach $4 billion in 2006, but will lose ground to corticosteroids.
- Corticosteroids are expected to rise the fastest, at an AAGR of 11.8% to $3.98 billion in 2006, representing 41.5% of the market at that time.
- The mast cell stabilizers segment will be the second fastest growing and will rise at an AAGR of 8.9% from $340 million in 2001 to $520 million in 2006.
- Sympathomimetics, decongestants and combinations were valued at $930 million in 2001 and will rise at an AAGR of only 3.2% to $1.09 billion in 2006.
Related Reports
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Sinus Dilation Devices Market
The global market for sinus dilation devices is estimated to increase from $2.6 billion in 2023 to reach $3.8 billion by 2028, at a compound annual growth rate (CAGR) of 8.4% from 2023 through 2028.
Markets for Advanced Wound Management Technologies
The global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.
Antibiotics: Technologies and Global Markets
The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.
Recent Reports
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More